Edoxaban
Edoxaban | CAS NO: 480449-70-5, Edoxaban is an oral anticoagulant (blood thinner) that is used primarily for the prevention and treatment of blood clots. It works by inhibiting a clotting factor called Factor Xa, which plays a crucial role in the blood clotting process.
We are the Synchemia Research Chemical specializes in manufacturing and supplying of Edoxaban impurities that meet specific pharmacopeial standards (EP/BP/USP/IP) as well as process-related impurities Edoxaban is prescribed to reduce the risk of stroke and blood clots in patients with non-valvular atrial fibrillation (AF), a condition where the heart's upper chambers beat irregularly, increasing the likelihood of clot formation. Buy Reliable and High-Purity Edoxaban Impurities, Delivered by Synchemia Research Chemicals.
Pharmaceutical Reference Standards
| CAT No | SRC-E39320 |
| CAS No | 5350-93-6 |
| Mol.F. | C5H5ClN2 |
| Mol.Wt. | 128.6g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39321 |
| CAS No | NA |
| Mol.F. | C11H16N3O4 |
| Mol.Wt. | 254.3g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39322 |
| CAS No | 88-20-0 |
| Mol.F. | C7H8O3S |
| Mol.Wt. | 172.2g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39323 |
| CAS No | 2759920-22-2 |
| Mol.F. | C25H33N5O4S |
| Mol.Wt. | 499.6g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39324 |
| CAS No | NA |
| Mol.F. | C24H30ClN7O4S |
| Mol.Wt. | 548.1g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39325 |
| CAS No | NA |
| Mol.F. | C24H30ClN7O4S |
| Mol.Wt. | 548.1g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39326 |
| CAS No | NA |
| Mol.F. | C24H30ClN7O4S |
| Mol.Wt. | 548.1g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39327 |
| CAS No | 2752546-54-4 |
| Mol.F. | C9H8Cl2N2O3 |
| Mol.Wt. | 263.1g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39328 |
| CAS No | 365998-34-1 |
| Mol.F. | C20H28N2O6 |
| Mol.Wt. | 392.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39329 |
| CAS No | 4755-77-5 |
| Mol.F. | C4H5ClO3 |
| Mol.Wt. | 136.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39330 |
| CAS No | 143150-92-9 |
| Mol.F. | C7H9BrN2S |
| Mol.Wt. | 233.1g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39331 |
| CAS No | NA |
| Mol.F. | C10H17N3O2 |
| Mol.Wt. | 211.3g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39332 |
| CAS No | NA |
| Mol.F. | C13H25N3O3 |
| Mol.Wt. | 271.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39333 |
| CAS No | NA |
| Mol.F. | C12H22N2O4 |
| Mol.Wt. | 258.3g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39334 |
| CAS No | NA |
| Mol.F. | C21H30ClN5O5 |
| Mol.Wt. | 468g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39335 |
| CAS No | NA |
| Mol.F. | C21H30ClN5O5 |
| Mol.Wt. | 468g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Let’s advance your research together.
Partner with us for specialized chemical materials and synthesis services that enable pharmaceutical innovation.